See more : Petratherm Limited (PTR.AX) Income Statement Analysis – Financial Results
Complete financial analysis of Allianz SE (ALIZY) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Allianz SE, a leading company in the Insurance – Diversified industry within the Financial Services sector.
- Inovio Pharmaceuticals, Inc. (GBMB.F) Income Statement Analysis – Financial Results
- Sidiz.Inc. (134790.KS) Income Statement Analysis – Financial Results
- The BC Bud Corporation (BCBCF) Income Statement Analysis – Financial Results
- The Netplex Group, Inc. (NTPL) Income Statement Analysis – Financial Results
- Hangzhou Changchuan Technology Co.,Ltd (300604.SZ) Income Statement Analysis – Financial Results
Allianz SE (ALIZY)
About Allianz SE
Allianz SE, together with its subsidiaries, provides property-casualty insurance, life/health insurance, and asset management products and services worldwide. The company's Property-Casualty segment offers various insurance products, including motor liability and own damage, accident, general liability, fire and property, legal expense, credit, and travel to private and corporate customers. Its Life/Health segment provides a range of life and health insurance products on an individual and a group basis, such as annuities, endowment and term insurance, and unit-linked and investment-oriented products, as well as private and supplemental health, and long-term care insurance products. The company's Asset Management segment offers institutional and retail asset management products and services to third-party investors comprising equity and fixed income funds, and multi-assets; and alternative investment products comprising infrastructure debt/equity, real assets, liquid alternatives, and solutions. Its Corporate and Other segment provides banking services for retail clients, as well as digital investment services. Allianz SE was founded in 1890 and is headquartered in Munich, Germany.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2000 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 103.01B | 114.30B | 118.91B | 112.24B | 113.00B | 102.98B | 107.43B | 107.51B | 107.58B | 101.09B | 99.65B | 99.84B | 91.90B | 94.35B | 87.20B | 81.00B | 99.74B | 86.58B | 92.46B | 77.09B |
Cost of Revenue | -58.69B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Gross Profit | 161.70B | 114.30B | 118.91B | 112.24B | 113.00B | 102.98B | 107.43B | 107.51B | 107.58B | 101.09B | 99.65B | 99.84B | 91.90B | 94.35B | 87.20B | 81.00B | 99.74B | 86.58B | 92.46B | 77.09B |
Gross Profit Ratio | 156.97% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 0.00 | 11.17B | 12.48B | 8.34B | 8.05B | 7.91B | 8.34B | 7.92B | 7.71B | 7.15B | 22.87B | 6.67B | 6.61B | 6.65B | 6.93B | 6.49B | 9.25B | 7.12B | 9.49B | 0.00 |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 0.00 | 11.17B | 12.48B | 8.34B | 8.05B | 7.91B | 8.34B | 7.92B | 7.71B | 7.15B | 22.87B | 6.67B | 6.61B | 6.65B | 6.93B | 6.49B | 9.25B | 7.12B | 9.49B | 0.00 |
Other Expenses | 103.01B | -114.83B | -127.92B | -107.17B | -112.03B | -99.69B | -104.88B | -104.30B | -104.25B | -98.51B | -111.90B | -96.72B | -92.44B | -92.57B | -87.76B | -86.75B | -91.50B | -83.32B | -89.13B | -73.44B |
Operating Expenses | 103.01B | -103.66B | -115.44B | -98.84B | -103.98B | -91.79B | -96.54B | -96.38B | -96.53B | -91.36B | -89.04B | -90.05B | -85.82B | -85.92B | -80.83B | -80.26B | -82.25B | -76.20B | -79.64B | -73.44B |
Cost & Expenses | 103.01B | 104.65B | 109.40B | 102.63B | 101.92B | 92.58B | 97.28B | 97.22B | 97.38B | 92.24B | 90.01B | 89.89B | 87.05B | 87.17B | 81.87B | 75.52B | 88.17B | 77.01B | 84.63B | 12.11B |
Interest Income | 25.39B | 23.98B | 22.04B | 20.39B | 21.50B | 20.73B | 20.95B | 21.26B | 21.22B | 20.40B | 19.98B | 20.20B | 19.55B | 18.55B | 17.46B | 18.41B | 24.69B | 16.40B | 21.40B | 0.00 |
Interest Expense | 0.00 | 1.44B | 1.16B | 999.00M | 1.11B | 1.04B | 1.15B | 1.21B | 1.22B | 1.26B | 1.32B | 1.48B | 1.49B | 1.41B | 1.48B | 1.89B | 6.67B | 1.63B | 6.38B | 0.00 |
Depreciation & Amortization | 2.27B | 323.00M | 2.53B | 2.24B | 2.07B | 1.59B | 1.54B | 1.35B | 1.36B | 1.16B | 1.11B | 1.12B | 1.05B | 1.10B | 902.00M | 640.00M | 891.00M | 983.00M | 787.00M | 0.00 |
EBITDA | 0.00 | 13.22B | 6.00B | 15.65B | 11.09B | 12.78B | 12.44B | 12.48B | 12.41B | 10.89B | 11.73B | 10.91B | 7.13B | 9.53B | 7.27B | 8.13B | 18.38B | 11.36B | 13.61B | 3.65B |
EBITDA Ratio | 0.00% | 11.56% | 5.04% | 13.94% | 9.81% | 12.41% | 11.58% | 11.61% | 11.53% | 10.77% | 11.77% | 10.93% | 7.76% | 10.10% | 8.34% | 1.70% | 18.43% | 13.12% | 14.72% | 4.73% |
Operating Income | 12.06B | 10.64B | 3.47B | 13.40B | 9.02B | 11.19B | 10.89B | 11.13B | 11.05B | 9.73B | 10.62B | 9.79B | 6.08B | 8.43B | 6.37B | 736.00M | 17.49B | 10.37B | 12.82B | 3.65B |
Operating Income Ratio | 11.70% | 9.31% | 2.92% | 11.94% | 7.98% | 10.87% | 10.14% | 10.35% | 10.27% | 9.62% | 10.65% | 9.80% | 6.61% | 8.93% | 7.30% | 0.91% | 17.54% | 11.98% | 13.87% | 4.73% |
Total Other Income/Expenses | -475.00M | -994.00M | 6.05B | -6.92B | -795.00M | -220.00M | -5.45B | 10.41B | 353.00M | 8.85B | -3.00B | -1.87B | 4.85B | 7.17B | 5.19B | 4.86B | 10.56B | 9.56B | 7.83B | 0.00 |
Income Before Tax | 11.58B | 9.65B | 9.52B | 9.60B | 11.08B | 10.40B | 10.15B | 10.29B | 10.20B | 8.85B | 9.64B | 8.63B | 4.85B | 7.17B | 5.33B | 5.47B | 11.57B | 9.56B | 7.83B | 30.68B |
Income Before Tax Ratio | 11.24% | 8.44% | 8.01% | 8.56% | 9.80% | 10.10% | 9.45% | 9.57% | 9.48% | 8.75% | 9.68% | 8.64% | 5.27% | 7.60% | 6.11% | 6.76% | 11.60% | 11.05% | 8.47% | 39.79% |
Income Tax Expense | 2.55B | 2.47B | 2.42B | 2.47B | 2.78B | 2.70B | 2.94B | 3.04B | 3.21B | 2.25B | 3.30B | 3.14B | 2.04B | 1.96B | 588.00M | 1.29B | 2.85B | 1.72B | 2.06B | 176.65M |
Net Income | 8.54B | 6.42B | 6.61B | 6.81B | 7.91B | 7.46B | 6.80B | 6.96B | 6.62B | 6.22B | 6.00B | 5.23B | 2.55B | 5.05B | 4.21B | -2.44B | 7.97B | 7.02B | 4.38B | 3.47B |
Net Income Ratio | 8.29% | 5.62% | 5.56% | 6.06% | 7.00% | 7.25% | 6.33% | 6.48% | 6.15% | 6.15% | 6.02% | 5.24% | 2.77% | 5.36% | 4.82% | -3.02% | 7.99% | 8.11% | 4.74% | 4.50% |
EPS | 21.16 | 15.86 | 15.96 | 16.48 | 18.90 | 1.74 | 1.52 | 1.53 | 1.46 | 1.37 | 1.32 | 1.16 | 0.56 | 1.12 | 0.93 | -0.54 | 1.80 | 1.71 | 1.12 | 1.41 |
EPS Diluted | 21.18 | 15.86 | 15.83 | 16.32 | 18.83 | 1.74 | 1.52 | 1.52 | 1.46 | 1.36 | 1.31 | 1.15 | 0.55 | 1.11 | 0.93 | -0.54 | 1.77 | 1.68 | 1.11 | 1.41 |
Weighted Avg Shares Out | 396.60M | 404.79M | 410.92M | 412.93M | 418.65M | 4.28B | 4.46B | 4.55B | 4.54B | 4.54B | 4.53B | 4.53B | 4.52B | 4.51B | 4.51B | 4.50B | 4.43B | 4.11B | 3.90B | 2.45B |
Weighted Avg Shares Out (Dil) | 396.32M | 404.79M | 411.69M | 414.46M | 418.75M | 4.30B | 4.47B | 4.57B | 4.54B | 4.54B | 4.53B | 4.53B | 4.53B | 4.53B | 4.52B | 4.56B | 4.50B | 4.18B | 3.93B | 2.45B |
My Top 10 High Dividend Yield Companies For June 2023
Why Allianz SE (ALIZY) is a Top Dividend Stock for Your Portfolio
My Dividend Stock Portfolio: New April Dividend Record - 99 Holdings With 21 Buys
Should Value Investors Buy Allianz (ALIZY) Stock?
Why Prudent Investors Are Adding AIG to Their Portfolio Now
Allianz profits surge on higher prices and fewer disasters
Allianz posts big jump in profit after year-earlier charge
Allianz SE (ALIZY) is a Top Dividend Stock Right Now: Should You Buy?
AIG Tops Q1 Earnings on Underwriting Gains, Ups Dividend
Allianz: A Healthy Level Of Caution Is Advised
Source: https://incomestatements.info
Category: Stock Reports